Cancer gene therapy by viral and non-viral vectors:
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
Hoboken, New Jersey
Wiley Blackwell
[2014]
|
Schriftenreihe: | Translational oncology
|
Schlagworte: | |
Online-Zugang: | Volltext Volltext |
Beschreibung: | Machine generated contents note: ContributorsSeries ForewordPreface Part I: Delivery Systems 1. Translational Cancer Research: Gene Therapy by Viral and Non-viral Vectors Vincenzo Cerullo, Kilian Guse, Markus Vaha-Koskela and Akseli Hemminki 2. Retroviruses for Cancer Therapy Jiehua Zhou, Yue Ding, John Burnett and John Rossi 3. DNA Plasmids for Non-viral Gene Therapy of Cancer Amer N. Najjar, Judy S.E. Moyes and Laurence J.N. Cooper 4. Cancer Therapy with RNAi delivered by Nonviral Membrane/Core Nanoparticles Andrew B. Satterlee and Leaf Huang Part II: Targeted Expression 5. Cancer Gene Therapy by Tissue-specific and Cancer-targeting Promoters Jennifer L. Hsu, Longfei Huo, Chia-Wei Li, Yi-Hsin Hsu, Yan Wang and Mien-Chie Hung 6. MicroRNAs as Drugs and Drug Targets in Cancer Hui Ling and George A. Calin Part III: Principles of Clinical Trials in Gene Therapy 7. Regulatory Issues for Manufacturers of Viral Vectors and Vector-Transduced Cells for Phase I/II Trials Adrian P. Gee and Zhuyong Mei 8. U.S. Regulations Governing Clinical Trials in Gene Therapy Bambi Grilley 9. Remaining Obstacles to the Success of Cancer Gene Therapy Malcolm K. BrennerIndex Includes bibliographical references and index "Translational medicine has opened the gateway to the era of personalized medicine. No longer a one-size-fits-all approach, the treatment of cancer is now based on an understanding of underlying biologic mechanisms and is increasingly being tailored to the molecular specificity of a tumor. Gene therapy in cancer has faced many technical barriers in the past but has recently shown significant progress that could allow stem cell and gene transfer therapies to make a major contribution to cancer therapy. The time appears ripe for a good, authoritative, book-length review of the state-of-the-art in this field. Gene Therapy by Viral and Non-viral Vectors provides a comprehensive overview of the pertinent molecular discoveries in the cancer field and explains the clinical ramifications and utility of these on gene-based cancer therapies. Designed as a volume in the book series Translational Oncology, edited by Robert Bast, Maurie Markman, and Ernest Hawk, this new book deals with the practice of gene therapy with reference to vectors for gene expression and gene transfer as well as viral therapy, and it will very nicely complement other books in the series, especially the volumes on immunotherapy and cell therapy. The content of the book also covers the history and current and future applications of gene transfer in cancer. This new volume provides expert insight on the current progress of viral and nonviral gene therapy with regard to delivery system, vector design, potential therapeutic genes, and principles and regulations for cancer gene therapy. It offers important and immediately applicable information to investigators, clinician-researchers, and medcial and graduate students with interest in this vital area of research"--Provided by publisher |
Beschreibung: | 1 Online-Ressource (xii, 162 pages) |
ISBN: | 9781118501641 1118501640 9781118501665 1118501667 1306473551 9781306473552 9781118501658 1118501659 9781118501627 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV042796336 | ||
003 | DE-604 | ||
005 | 20160614 | ||
007 | cr|uuu---uuuuu | ||
008 | 150902s2014 |||| o||u| ||||||eng d | ||
020 | |a 9781118501641 |c Online |9 978-1-118-50164-1 | ||
020 | |a 1118501640 |9 1-118-50164-0 | ||
020 | |a 9781118501665 |9 978-1-118-50166-5 | ||
020 | |a 1118501667 |9 1-118-50166-7 | ||
020 | |a 1306473551 |9 1-306-47355-1 | ||
020 | |a 9781306473552 |9 978-1-306-47355-2 | ||
020 | |a 9781118501658 |9 978-1-118-50165-8 | ||
020 | |a 1118501659 |9 1-118-50165-9 | ||
020 | |a 9781118501627 |9 978-1-118-50162-7 | ||
024 | 7 | |a 10.1002/9781118501665 |2 doi | |
035 | |a (OCoLC)867001327 | ||
035 | |a (DE-599)BVBBV042796336 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-861 | ||
082 | 0 | |a 616.99/4042 |2 23 | |
084 | |a XH 3500 |0 (DE-625)152892:12905 |2 rvk | ||
245 | 1 | 0 | |a Cancer gene therapy by viral and non-viral vectors |c edited by Malcolm K. Brenner, Mien-Chie Hung |
264 | 1 | |a Hoboken, New Jersey |b Wiley Blackwell |c [2014] | |
300 | |a 1 Online-Ressource (xii, 162 pages) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Translational oncology | |
500 | |a Machine generated contents note: ContributorsSeries ForewordPreface Part I: Delivery Systems 1. Translational Cancer Research: Gene Therapy by Viral and Non-viral Vectors Vincenzo Cerullo, Kilian Guse, Markus Vaha-Koskela and Akseli Hemminki 2. Retroviruses for Cancer Therapy Jiehua Zhou, Yue Ding, John Burnett and John Rossi 3. DNA Plasmids for Non-viral Gene Therapy of Cancer Amer N. Najjar, Judy S.E. Moyes and Laurence J.N. Cooper 4. Cancer Therapy with RNAi delivered by Nonviral Membrane/Core Nanoparticles Andrew B. Satterlee and Leaf Huang Part II: Targeted Expression 5. Cancer Gene Therapy by Tissue-specific and Cancer-targeting Promoters Jennifer L. Hsu, Longfei Huo, Chia-Wei Li, Yi-Hsin Hsu, Yan Wang and Mien-Chie Hung 6. MicroRNAs as Drugs and Drug Targets in Cancer Hui Ling and George A. Calin Part III: Principles of Clinical Trials in Gene Therapy 7. Regulatory Issues for Manufacturers of Viral Vectors and Vector-Transduced Cells for Phase I/II Trials Adrian P. Gee and Zhuyong Mei 8. U.S. Regulations Governing Clinical Trials in Gene Therapy Bambi Grilley 9. Remaining Obstacles to the Success of Cancer Gene Therapy Malcolm K. BrennerIndex | ||
500 | |a Includes bibliographical references and index | ||
500 | |a "Translational medicine has opened the gateway to the era of personalized medicine. No longer a one-size-fits-all approach, the treatment of cancer is now based on an understanding of underlying biologic mechanisms and is increasingly being tailored to the molecular specificity of a tumor. Gene therapy in cancer has faced many technical barriers in the past but has recently shown significant progress that could allow stem cell and gene transfer therapies to make a major contribution to cancer therapy. The time appears ripe for a good, authoritative, book-length review of the state-of-the-art in this field. Gene Therapy by Viral and Non-viral Vectors provides a comprehensive overview of the pertinent molecular discoveries in the cancer field and explains the clinical ramifications and utility of these on gene-based cancer therapies. Designed as a volume in the book series Translational Oncology, edited by Robert Bast, Maurie Markman, and Ernest Hawk, this new book deals with the practice of gene therapy with reference to vectors for gene expression and gene transfer as well as viral therapy, and it will very nicely complement other books in the series, especially the volumes on immunotherapy and cell therapy. The content of the book also covers the history and current and future applications of gene transfer in cancer. This new volume provides expert insight on the current progress of viral and nonviral gene therapy with regard to delivery system, vector design, potential therapeutic genes, and principles and regulations for cancer gene therapy. It offers important and immediately applicable information to investigators, clinician-researchers, and medcial and graduate students with interest in this vital area of research"--Provided by publisher | ||
650 | 7 | |a HEALTH & FITNESS / Diseases / General |2 bisacsh | |
650 | 7 | |a MEDICAL / Clinical Medicine |2 bisacsh | |
650 | 7 | |a MEDICAL / Diseases |2 bisacsh | |
650 | 7 | |a MEDICAL / Evidence-Based Medicine |2 bisacsh | |
650 | 7 | |a MEDICAL / Internal Medicine |2 bisacsh | |
650 | 4 | |a Neoplasms / therapy | |
650 | 4 | |a Genetic Therapy | |
650 | 4 | |a Genetic Vectors / therapeutic use | |
650 | 4 | |a Oncolytic Virotherapy | |
650 | 4 | |a Evidenz-basierte Medizin | |
650 | 4 | |a Innere Medizin | |
650 | 4 | |a Medizin | |
650 | 4 | |a Cancer |x Gene therapy | |
650 | 4 | |a Genetic vectors |x Therapeutic use | |
650 | 0 | 7 | |a Onkolyse |0 (DE-588)4172588-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Gentherapie |0 (DE-588)4296957-8 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 0 | 1 | |a Gentherapie |0 (DE-588)4296957-8 |D s |
689 | 0 | 2 | |a Onkolyse |0 (DE-588)4172588-8 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Brenner, Malcolm K. |e Sonstige |4 oth | |
700 | 1 | |a Hung, Mien-Chie |e Sonstige |4 oth | |
856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9781118501665 |x Wiley |3 Volltext |
856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=707179 |x Aggregator |3 Volltext |
912 | |a ZDB-4-NLEBK |a ZDB-35-WIC | ||
940 | 1 | |q FRO_PDA_WIC | |
940 | 1 | |q UBG_PDA_WIC | |
940 | 1 | |q FHR_PDA_WIC | |
999 | |a oai:aleph.bib-bvb.de:BVB01-028226108 |
Datensatz im Suchindex
_version_ | 1804175029241380864 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV042796336 |
classification_rvk | XH 3500 |
collection | ZDB-4-NLEBK ZDB-35-WIC |
ctrlnum | (OCoLC)867001327 (DE-599)BVBBV042796336 |
dewey-full | 616.99/4042 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.99/4042 |
dewey-search | 616.99/4042 |
dewey-sort | 3616.99 44042 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05741nmm a2200769zc 4500</leader><controlfield tag="001">BV042796336</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20160614 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150902s2014 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118501641</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-118-50164-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1118501640</subfield><subfield code="9">1-118-50164-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118501665</subfield><subfield code="9">978-1-118-50166-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1118501667</subfield><subfield code="9">1-118-50166-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1306473551</subfield><subfield code="9">1-306-47355-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781306473552</subfield><subfield code="9">978-1-306-47355-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118501658</subfield><subfield code="9">978-1-118-50165-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1118501659</subfield><subfield code="9">1-118-50165-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118501627</subfield><subfield code="9">978-1-118-50162-7</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/9781118501665</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)867001327</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042796336</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-861</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4042</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3500</subfield><subfield code="0">(DE-625)152892:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cancer gene therapy by viral and non-viral vectors</subfield><subfield code="c">edited by Malcolm K. Brenner, Mien-Chie Hung</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, New Jersey</subfield><subfield code="b">Wiley Blackwell</subfield><subfield code="c">[2014]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xii, 162 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Translational oncology</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Machine generated contents note: ContributorsSeries ForewordPreface Part I: Delivery Systems 1. Translational Cancer Research: Gene Therapy by Viral and Non-viral Vectors Vincenzo Cerullo, Kilian Guse, Markus Vaha-Koskela and Akseli Hemminki 2. Retroviruses for Cancer Therapy Jiehua Zhou, Yue Ding, John Burnett and John Rossi 3. DNA Plasmids for Non-viral Gene Therapy of Cancer Amer N. Najjar, Judy S.E. Moyes and Laurence J.N. Cooper 4. Cancer Therapy with RNAi delivered by Nonviral Membrane/Core Nanoparticles Andrew B. Satterlee and Leaf Huang Part II: Targeted Expression 5. Cancer Gene Therapy by Tissue-specific and Cancer-targeting Promoters Jennifer L. Hsu, Longfei Huo, Chia-Wei Li, Yi-Hsin Hsu, Yan Wang and Mien-Chie Hung 6. MicroRNAs as Drugs and Drug Targets in Cancer Hui Ling and George A. Calin Part III: Principles of Clinical Trials in Gene Therapy 7. Regulatory Issues for Manufacturers of Viral Vectors and Vector-Transduced Cells for Phase I/II Trials Adrian P. Gee and Zhuyong Mei 8. U.S. Regulations Governing Clinical Trials in Gene Therapy Bambi Grilley 9. Remaining Obstacles to the Success of Cancer Gene Therapy Malcolm K. BrennerIndex</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Translational medicine has opened the gateway to the era of personalized medicine. No longer a one-size-fits-all approach, the treatment of cancer is now based on an understanding of underlying biologic mechanisms and is increasingly being tailored to the molecular specificity of a tumor. Gene therapy in cancer has faced many technical barriers in the past but has recently shown significant progress that could allow stem cell and gene transfer therapies to make a major contribution to cancer therapy. The time appears ripe for a good, authoritative, book-length review of the state-of-the-art in this field. Gene Therapy by Viral and Non-viral Vectors provides a comprehensive overview of the pertinent molecular discoveries in the cancer field and explains the clinical ramifications and utility of these on gene-based cancer therapies. Designed as a volume in the book series Translational Oncology, edited by Robert Bast, Maurie Markman, and Ernest Hawk, this new book deals with the practice of gene therapy with reference to vectors for gene expression and gene transfer as well as viral therapy, and it will very nicely complement other books in the series, especially the volumes on immunotherapy and cell therapy. The content of the book also covers the history and current and future applications of gene transfer in cancer. This new volume provides expert insight on the current progress of viral and nonviral gene therapy with regard to delivery system, vector design, potential therapeutic genes, and principles and regulations for cancer gene therapy. It offers important and immediately applicable information to investigators, clinician-researchers, and medcial and graduate students with interest in this vital area of research"--Provided by publisher</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Clinical Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Diseases</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Evidence-Based Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Internal Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetic Therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetic Vectors / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncolytic Virotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Evidenz-basierte Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Innere Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Gene therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetic vectors</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Onkolyse</subfield><subfield code="0">(DE-588)4172588-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gentherapie</subfield><subfield code="0">(DE-588)4296957-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Gentherapie</subfield><subfield code="0">(DE-588)4296957-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Onkolyse</subfield><subfield code="0">(DE-588)4172588-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brenner, Malcolm K.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hung, Mien-Chie</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9781118501665</subfield><subfield code="x">Wiley</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=707179</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield><subfield code="a">ZDB-35-WIC</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FRO_PDA_WIC</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">UBG_PDA_WIC</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FHR_PDA_WIC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028226108</subfield></datafield></record></collection> |
id | DE-604.BV042796336 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:09:47Z |
institution | BVB |
isbn | 9781118501641 1118501640 9781118501665 1118501667 1306473551 9781306473552 9781118501658 1118501659 9781118501627 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028226108 |
oclc_num | 867001327 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-861 |
owner_facet | DE-355 DE-BY-UBR DE-861 |
physical | 1 Online-Ressource (xii, 162 pages) |
psigel | ZDB-4-NLEBK ZDB-35-WIC FRO_PDA_WIC UBG_PDA_WIC FHR_PDA_WIC |
publishDate | 2014 |
publishDateSearch | 2014 |
publishDateSort | 2014 |
publisher | Wiley Blackwell |
record_format | marc |
series2 | Translational oncology |
spelling | Cancer gene therapy by viral and non-viral vectors edited by Malcolm K. Brenner, Mien-Chie Hung Hoboken, New Jersey Wiley Blackwell [2014] 1 Online-Ressource (xii, 162 pages) txt rdacontent c rdamedia cr rdacarrier Translational oncology Machine generated contents note: ContributorsSeries ForewordPreface Part I: Delivery Systems 1. Translational Cancer Research: Gene Therapy by Viral and Non-viral Vectors Vincenzo Cerullo, Kilian Guse, Markus Vaha-Koskela and Akseli Hemminki 2. Retroviruses for Cancer Therapy Jiehua Zhou, Yue Ding, John Burnett and John Rossi 3. DNA Plasmids for Non-viral Gene Therapy of Cancer Amer N. Najjar, Judy S.E. Moyes and Laurence J.N. Cooper 4. Cancer Therapy with RNAi delivered by Nonviral Membrane/Core Nanoparticles Andrew B. Satterlee and Leaf Huang Part II: Targeted Expression 5. Cancer Gene Therapy by Tissue-specific and Cancer-targeting Promoters Jennifer L. Hsu, Longfei Huo, Chia-Wei Li, Yi-Hsin Hsu, Yan Wang and Mien-Chie Hung 6. MicroRNAs as Drugs and Drug Targets in Cancer Hui Ling and George A. Calin Part III: Principles of Clinical Trials in Gene Therapy 7. Regulatory Issues for Manufacturers of Viral Vectors and Vector-Transduced Cells for Phase I/II Trials Adrian P. Gee and Zhuyong Mei 8. U.S. Regulations Governing Clinical Trials in Gene Therapy Bambi Grilley 9. Remaining Obstacles to the Success of Cancer Gene Therapy Malcolm K. BrennerIndex Includes bibliographical references and index "Translational medicine has opened the gateway to the era of personalized medicine. No longer a one-size-fits-all approach, the treatment of cancer is now based on an understanding of underlying biologic mechanisms and is increasingly being tailored to the molecular specificity of a tumor. Gene therapy in cancer has faced many technical barriers in the past but has recently shown significant progress that could allow stem cell and gene transfer therapies to make a major contribution to cancer therapy. The time appears ripe for a good, authoritative, book-length review of the state-of-the-art in this field. Gene Therapy by Viral and Non-viral Vectors provides a comprehensive overview of the pertinent molecular discoveries in the cancer field and explains the clinical ramifications and utility of these on gene-based cancer therapies. Designed as a volume in the book series Translational Oncology, edited by Robert Bast, Maurie Markman, and Ernest Hawk, this new book deals with the practice of gene therapy with reference to vectors for gene expression and gene transfer as well as viral therapy, and it will very nicely complement other books in the series, especially the volumes on immunotherapy and cell therapy. The content of the book also covers the history and current and future applications of gene transfer in cancer. This new volume provides expert insight on the current progress of viral and nonviral gene therapy with regard to delivery system, vector design, potential therapeutic genes, and principles and regulations for cancer gene therapy. It offers important and immediately applicable information to investigators, clinician-researchers, and medcial and graduate students with interest in this vital area of research"--Provided by publisher HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Neoplasms / therapy Genetic Therapy Genetic Vectors / therapeutic use Oncolytic Virotherapy Evidenz-basierte Medizin Innere Medizin Medizin Cancer Gene therapy Genetic vectors Therapeutic use Onkolyse (DE-588)4172588-8 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Gentherapie (DE-588)4296957-8 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 s Gentherapie (DE-588)4296957-8 s Onkolyse (DE-588)4172588-8 s DE-604 Brenner, Malcolm K. Sonstige oth Hung, Mien-Chie Sonstige oth https://onlinelibrary.wiley.com/doi/book/10.1002/9781118501665 Wiley Volltext http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=707179 Aggregator Volltext |
spellingShingle | Cancer gene therapy by viral and non-viral vectors HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Neoplasms / therapy Genetic Therapy Genetic Vectors / therapeutic use Oncolytic Virotherapy Evidenz-basierte Medizin Innere Medizin Medizin Cancer Gene therapy Genetic vectors Therapeutic use Onkolyse (DE-588)4172588-8 gnd Krebs Medizin (DE-588)4073781-0 gnd Gentherapie (DE-588)4296957-8 gnd |
subject_GND | (DE-588)4172588-8 (DE-588)4073781-0 (DE-588)4296957-8 |
title | Cancer gene therapy by viral and non-viral vectors |
title_auth | Cancer gene therapy by viral and non-viral vectors |
title_exact_search | Cancer gene therapy by viral and non-viral vectors |
title_full | Cancer gene therapy by viral and non-viral vectors edited by Malcolm K. Brenner, Mien-Chie Hung |
title_fullStr | Cancer gene therapy by viral and non-viral vectors edited by Malcolm K. Brenner, Mien-Chie Hung |
title_full_unstemmed | Cancer gene therapy by viral and non-viral vectors edited by Malcolm K. Brenner, Mien-Chie Hung |
title_short | Cancer gene therapy by viral and non-viral vectors |
title_sort | cancer gene therapy by viral and non viral vectors |
topic | HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Neoplasms / therapy Genetic Therapy Genetic Vectors / therapeutic use Oncolytic Virotherapy Evidenz-basierte Medizin Innere Medizin Medizin Cancer Gene therapy Genetic vectors Therapeutic use Onkolyse (DE-588)4172588-8 gnd Krebs Medizin (DE-588)4073781-0 gnd Gentherapie (DE-588)4296957-8 gnd |
topic_facet | HEALTH & FITNESS / Diseases / General MEDICAL / Clinical Medicine MEDICAL / Diseases MEDICAL / Evidence-Based Medicine MEDICAL / Internal Medicine Neoplasms / therapy Genetic Therapy Genetic Vectors / therapeutic use Oncolytic Virotherapy Evidenz-basierte Medizin Innere Medizin Medizin Cancer Gene therapy Genetic vectors Therapeutic use Onkolyse Krebs Medizin Gentherapie |
url | https://onlinelibrary.wiley.com/doi/book/10.1002/9781118501665 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=707179 |
work_keys_str_mv | AT brennermalcolmk cancergenetherapybyviralandnonviralvectors AT hungmienchie cancergenetherapybyviralandnonviralvectors |